Our lab overcomes cell therapy barriers in solid tumors. We focus on TCR Discovery—using advanced technology to find tumor-specific TCRs; Antigen Identification—pinpointing peptides for safe TCR-T products; and Next-Gen T Cell Edits—enhancing T cell function via high-throughput genetics.